In vitro regulation of corticotropin-releasing hormone

Life Sciences

Volumn 73, Issue 6, 2003, Pages 769-781

  Kasckow, J W ^a,b,c   Aguilera, G ^d   Mulchahey, J J ^e   Sheriff, S ^b   Herma, J P ^b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

^d EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^e Phase 2 Discovery Inc   (United States)

Author keywords

Amygdala; Corticotropin releasing hormone; Culture; Hypothalamus; In vitro; Stress

Indexed keywords

ACETYLCHOLINE; ALPHA ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ATROPINE; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOGENIC AMINE; CALCIUM; CORTICOTROPIN RELEASING FACTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; CYTOKINE; DEXAMETHASONE; GLUCOCORTICOID; HEXAMETHONIUM; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 6; NEUROTRANSMITTER; NORADRENALIN; PHENTOLAMINE; PHORBOL 13 ACETATE 12 MYRISTATE; POTASSIUM CHLORIDE; PRAZOSIN; PROOPIOMELANOCORTIN; PROPRANOLOL; PROTEIN KINASE C ACTIVATOR; PROTEIN KINASE C INHIBITOR; SEROTONIN; UNINDEXED DRUG;

ADRENAL CORTEX; ADRENALECTOMY; ALCOHOL WITHDRAWAL; AMYGDALOID NUCLEUS; CELL CLONE; CELL LINE; CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; EXPLORATORY BEHAVIOR; GENE CONTROL; GENE EXPRESSION; HUMAN; HYPOTHALAMUS; IMMOBILIZATION STRESS; IMMUNOREACTIVITY; IN VITRO STUDY; LOCOMOTION; MODEL; NERVE CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; STIMULUS; STRESS;

EID: 0038173571     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(03)00409-0     Document Type: Conference Paper

References (83)

1. Adler G.K., Rosen L.B., Fiandaca M.J., Majzoub J.A. Protein kinase C activation increases the quantity and poly (A) tail length of corticotropin-releasing hormone messenger RNA in NPLC cells. Molecular Endocrinology. 6:1992;476-484.
2. Adler G.K., Smas C.M., Majzoub J. Expression and dexamethasone regulation of the human corticotropin-releasing hormone gene in a mouse anterior pituitary cell line. Journal of Biological Chemistry. 263:1988;5846-5852.
3. Beyer H.S., Matta S.G., Sharp B.M. Regulation of the messenger ribonucleic acid for corticotropin releasing factor in the paraventricular nucleus and other brain sites of the rat. Endocrinology. 123:1988;2117-2123.
4. Buzetti R., Tsagarakis S., Laveneder P., Rees L.H., Besser G.M., Grossman A. Effects of cytokines and epidermal growth on CRF-41 release from rat hypothalamus in vitro. Journal of Endocrinology. 119:1988;95. [Suppl.].
5. Calogero A.E., Gallucci W.T., Bernardini R., Saoutis C., Gold P.W., Chrousos G.P. Effect of cholinergic agonists and antagonists on rat hypothalamic corticotropin-releasing hormone secretion in vitro. Neuroendocrinology. 47:1988;303-308.
6. Calogero A.E., Kamilaris T.C., Gomez M.T., Johnson E.O., Tartaglia M.E., Gold P.W., Chrousos G.P. The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamic-pituitary-adrenal axis through a centrally-mediated corticotropin-releasing hormone-dependent mechanism. Endocrinology. 125:1989;2445-2453.
7. Cambronero J.C., Rivas F.J., Borell J., Guaza C. Interleukin-2 induces corticotropin-releasing hormone release from superfused rat hypothalami: Influence of glucocorticoids. Endocrinology. 131:1992;677-683.
8. Charney D., Deutch A.Y., Krystal J.H., Southwick S.M., Davis M. Psychobiologic mechanisms of posttraumatic stress disorder. Archives of General Psychiatry. 50:1993;295-305.
9. Chowdrey H.S., Larsen P.J., Harbuz M.S., Lightman S.L., Jessop D.S. Endogenous substance P inhibits the expression of corticotropin-releasing hormone during a chronic inflammatory stress. Life Sciences. 57:1995;2021-2029.
10. Clauw D.J., Chrousos G.P. Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. Neuroimmunomodulation. 4:1997;134-153.
11. Costa A., Trainer P., Besser M., Grossman A. Nitric oxide modulates the release of corticotropin releasing hormone from the rat hypothalamus in vitro. Brain Research. 605:1993;187-192.
12. Cratty M.S., Birkle D.L. N-methyl-D-aspartate (NMDA)-mediated corticotropin-releasing factor (CRF) release in cultured rat amygdala neurons. Peptides. 20:1999;93-100.
13. Cummings S., Elde R., Ells J., Lindall A. Corticotropin-releasing factor immunoreactivity is widely distributed within the central nervous system of the rat. Journal of Neuroscience. 3:1983;1355-1368.
14. Davis M. Anatomic and physiologic substrates of emotion in an animal model. Journal of Clinical Neurophysiology. 15:1998;378-387.
15. Emanuel R.L., Girard D.M., Thull D.L., Majzoub J.A. Second messengers involved in the regulation of corticotropin releasing hormone mRNA and peptide in cultured rat fetal hypothalamic primary cultures. Endocrinology. 126:1990;3016-3021.
16. Fehm H.L., Voigt K.H., Lang R.E., Pfeiffer E.F. Effects of neurotransmitters on the release of corticotropin-releasing hormone (CRH) by rat hypothalamic tissue in vitro. Experimental Brain Research. 39:1980;229-234.
17. Gibbs D.M., Vale W.W. Effect of the serotonin reuptake inhibitor on corticotropin-releasing factor and vasopression secretion into hypophysial blood. Brain Research. 386:1986;232-236.
18. Gill P.S., Regmi A., Porter-Gill P.A., Kasckow J.W. Interleukin-1 regulation of corticotropin releasing factor (CRF), glucocorticoid receptor, c-Fos and c-Jun messenger RNA in the NPLC-KC cell line. Mol Cell Endocrinology. 137:1998;31-39.
19. Grossman A., Costa A., Navarra P., Tsagarakis S. The regulation of hypothalamic corticotropin releasing factor release: in vitro studies. Ciba Foundation Symposium. 172:1993;129-143.
20. Guardiola-Diaz H.M., Boswell C., Seasholtz C., Seasholtz A.F. The cAMP responsive element in the corticotropin-releasing hormone gene mediates transcriptional regulation by depolarization. Journal of Biological Chemistry. 269:1994;14784-14791.
21. Guardiola-Diaz H.M., Kolinske J.S., Gates L.H., Seasholtz A.F. Negative glucocorticoid regulation of cyclic adenosine 3′,5′- monophosphate-stimulated corticotropin-releasing hormone-reporter expression in AtT20 cells. Molecular Endocrinology. 10:1996;317-329.
22. Harbuz M.S., Stephanou A., Knight R.A., Chover-Gonzalez A.J., Lightman S.L. Action of interleukin-2 and interleukin-4 on CRF mRNA in the hypothalamus and POMC mRNA in the anterior pituitary. Brain Behavior and Immunity. 6:1992;214-222.
23. Hedge G.A., Smelik P.G. Corticotropin release: Inhibition by intrahypothalamic implantation of atropine. Science. 159:1968;891-892.
24. Heinrichs S.C., Pich E.M., Miczek K., Britton K.T., Koob G.F. Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action. Brain Research. 581:1992;190-197.
25. Herman J.P., Prewitt C.M.F., Cullinan W.E. Neuronal circuit regulation of the hypothalamo pituitary-adrenocortical stress axis. Critical Reviews in Neurobiology. 10:1996;371-394.
26. Herman J.P., Schafer M.K.H., Thompson R.C., Watson S.J. Rapid regulation of corticotropin releasing hormone gene transcription in vivo. Molecular Endocrinology. 6:1992;1061-1069.
27. Hillhouse E.W., Burden J., Jones M T. The effect of various putative neurotransmitters on the release of corticotrophin releasing hormone from the hypothalamus of the rat in vitro. I. The effect of acetylcholine and noradrenaline. Neuroendocrinology. 17:1975;1-11.
28. Hillhouse E.W., Milton N.G. Effect of acetylcholine and 5-hydroxytryptamine on the secretion of corticotrophin-releasing factor-41 and arginine vasopressin from the rat hypothalamus in vitro. Journal of Endocrinology. 122:1989;713-718.
29. Hillhouse E., Reichlin S. Acetylcholine stimulates the secretion of corticotropin-releasing factor from primary dissociated cell culture of the rat telencephalon and diencephalon. Brain Research. 506:1990;9-13.
30. Hu S.B., Lightman S.L., Tannahill L.A. 5-Hydroxytryptamine stimulates corticosteroid-sensitive CRF release from cultured foetal hypothalamic cells. Role of protein kinases. Brain Research. 574:1992;266-270.
31. Hu S.-B., Tannahill L.A., Biswas S., Lightman S.L. Release of corticotropin-releasing factor-41, arginine vasopressin and oxytocin from rat fetal hypothalamic cells in culture: response to activation of second messengers and to corticosteroids. Journal of Endocrinology. 132:1991;57-65.
32. Imaki J., Imaki T., Vale W., Sawchenko P.E. Distribution of corticotropin-releasing factor mRNA and immunoreactivity in the central auditory system of the rat. Brain Research. 547:1991;28-36.
33. Itoi K., Mouri T., Takahashi K., Murakami O., Imai Y., Sasaki S., Yoshinaga K., Sasano N. Suppression by glucocorticoid of the immunoreactivity of corticotropin-releasing factor and vasopressin in the paraventricular nucleus of rat hypothalamus. Neuroscience Letters. 73:1987;231-236.
34. Jingami H., Matsukura S., Numa S., Imura H. Effects of adrenalectomy on the level of prepro- corticotropin-releasing factor messenger ribonucleic acid (mRNA) in the hypothalamus and adrenocorticotropin/β-lipotropin precursor mRNA in the pituitary in rats. Endocrinology. 117:1985;1314-1320.
35. Ju G., Swanson L.W., Simerly R.B. Studies on the cellular architecture of the bed nucleus of the stria terminalis of the rat: II. Chemoachitecture. Journal of Comparative Neurology. 280:1989;603-621.
36. Kalin N.H., Takahashi L.K., Chen R.L. Restraint stress increases corticotropin-releasing hormone mRNA content in the amygdala and paraventricular nucleus. Brain Research. 656:1994;182-186.
37. Karnath S., Lyson K., McCann S.M. Role of nitric oxide in interleukin 2-induced corticotropin releasing factor release from incubated hypothalami. Proceedings of the National Academy of Sciences (USA). 90:1993;3383-3387.
38. Kasckow J.W., Mulchahey J., Han J., Owens M.J., Nemeroff C.B. Interleukin 1α induces corticotropin-releasing factor secretion and synthesis from NPLC-KC cells through various second messenger pathways. Synapse. 18:1994;354-358.
39. Kasckow J., Mulchahey J.J., Aguilera G., Pisarska M., Nikodemova M., Chen H.-C., Herman J.P., Murphy E.K., Liu Y., Rizvi T.A., Dautzenberg F.M., Sheriff S. Corticotropin-releasing hormone (CRH) expression and protein kinase A mediated CRH receptor signalling in an immortalized hypothalamic cell line. Journal of Neuroendrocrinology. 15:2003;521-529.
40. Kasckow J.W., Han J., Mulchahey J.J., Owens M.J., Risby E.D., Fisher J., Nemeroff C.B. Regulation of corticotropin-releasing factor secretion and synthesis in the human neuroblastoma clones-BE(2)-M17 and BE(2)-C. Journal of Neuroendocrinology. 7:1995;461-466.
41. Kasckow J.W., Regmi A., Gill P.S., Parkes D.G., Geracioti T.D. Regulation of corticotropin releasing factor (CRF) messenger RNA and CRF peptide in the amygdala: Studies in primary amygdalar cultures. Endocrinology. 138:1997;4774-4782.
42. Kathol R.G., Jaeckle R.S., Lopez J.F. Pathophysiology of HPA axis: abnormalities in patients with major depression: an update. American Journal of Psychiatry. 146:1989;311.
43. Kim C.K., Rivier C.L. Nitric oxide and carbon monoxide have a stimulatory role in the hypothalamic-pituitary-adrenal response to physico-emotional stressors in rats. Endocrinology. 141:2000;2244-2253.
44. Korte S.M., Van Duin S., Bouws G.A.H., Koolhaas J.M., Bohus B. Involvement of hypothalamic serotonin in activation of the sympathoadrenomedullary system and hypothalamic-pituitary adrenocortical axis in male Wistar rats. European Journal of Pharmacology. 197:1991;225-228.
45. Lee S., Kim C.K., Rivier C. Nitric oxide appears to stimulate hypothalamic CRH in vivo, NGFI B, corticotropin-releasing factor, corticotropin-releasing factor receptor type 1, and vasopressin in the hypothalamus of the intact rat. Journal of Neuroscience. 19:1999;7640-7647.
46. Liang K.C., Lee E.H.Y. Intra-amygdala injections of corticotropin-releasing factor facilitate inhibitory avoidance learning and reduce exploratory behavior in rats. Psychopharmacology. 96:1988;232-236.
47. Lyson K., McCann S.M. Alpha-melanocyte-stimulating hormone abolishes IL-1- and IL-6 induced corticotropin-releasing factor release from the hypothalamus in vitro. Neuroendocrinology. 58:1993;191-195.
48. Makara G.B., Stark E. Effect of gamma-aminobutyric acid (GABA) and GABA antagonist drugs on ACTH release release. Neuroendocrinology. 16:1974;178-190.
49. Makino S., Gold P.W., Schulkin J. Corticosterone effects on corticotropin-releasing hormone mRNA in the central nucleus of the amygdala and the parvocellular region of the paraventricular nucleus of the hypothalamus. Brain Research. 640:1994;105-112.
50. Malkowski S.P., Handanos C.M., Dorin R.I. Localization of a negative glucocorticoid response element of the human corticotropin-releasing hormone gene. Molecular and Cellular Endocrinology. 127:1997;189-199.
51. McEwen B. Re-examination of the glucocorticoid hypothesis of stress and aging. Progress in Brain Research. 93:1992;365-381.
52. McEwen B.S., Stellar E. Stress and the individual. Mechanisms leading to disease. Archives of Internal Medicine. 153:1993;2093.
53. Mezey E., Palkovits M. Time dependent changes in CRF and its mRNA in the neurons of the inferior olive following surgical transection of the olivocerebellar tract in the rat. Molecular Brain Research. 10:1991;55-59.
54. Nakagami Y., Suda T., Yajima F., Ushiyama T., Tomori N., Sumitomo T., Demura H., Shizume K. Effects of serotonin, cryproheptadine and reserpine on corticotropin-releasing factor release from the rat hypothalamus in vitro. Brain Research. 386:1986;232-236.
55. Navarra P., Tsagarakis S., Faria M.S., Rees L.H., Besser G.M., Grossman A. Interleukin-1 and -6 stimulate the release of corticotropin-releasing hormone-41 from rat hypothalamus in vitro via the eicosanoid cyclooxygenase pathway. Endocrinology. 128:1991;37-44.
56. Nikodemova M., Kasckow J.W., Manganiello V., Aguilera G. Cyclic adenosine monophosphate regulation of CRH promoter activity in AtT-20 cells and in a transformed hypothalamic cell. Endocrinology. 144:2003;1292-1300.
57. Ohmori N., Itoi K., Tozawa F., Sakai Y., Sakai K., Horiba N., Demura H., Suda T. Effect of acetylcholine on corticotropin-releasing factor gene expression in the hypothalamic paraventricular nucleus of conscious rats. Endocrinology. 136:1995;4858-4863.
58. Parkes D., Kasckow J.W., Vale W.W. Carbon Monoxide Modulates Secretion of Corticotropin Releasing Factor (CRF) from Rat Hypothalamic Cell Cultures. Brain Research. 64:1994;315-318.
59. Parkes D.G., Yamamoto G.Y., Vaughan J.M., Vale W.W. Characterization and regulation of corticotropin-releasing factor in the human hepatoma NPLC-KC cell line. Neuroendocrinology. 57:1993;663-669.
60. Phi L. Phorbol ester stimulates the activity of human corticotropin-releasing hormone gene promoter via 3′,5′-cyclic adenosine monophophate response element in transiently transfected chicken macrophages. Endocrinology. 132:1993;30-34.
61. Pich E.M., Lorang M., Yeganeh M., Rodriguez de Fonseca F., Raber J., Koob G.F., Weiss F. Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. Journal of Neuroscience. 15:1995;5439-5447.
62. Pozzoli G., Mancuso C., Mirtella A., Preziosi P., Grossman A.B., Navarra P. Carbon Monoxide as a novel modulator: Inhibition of stimulated CRH from acute hypothalamic explants. Endocrinology. 135:1994;2314-2317.
63. Raber J., Koob G.F., Bloom F.E. Interleukin-2 (IL-2) induces corticotropin-releasing factor (CRF) release from the amygdala and involves a nitric oxide-mediated signalling; comparison with the hypothalamic response. Journal of Pharmacology and Experimental Therapeutics. 272:1995;815-824.
64. Rivier J., Speiss J., Vale W. Characterization of rat hypothalamic corticotropin-releasing factor. Proceedings of the National Academy of Sciences (USA). 80:1983;4851-4855.
65. Russell S.H., Small C.J., Dakin C.L., Abbott C.R., Morgan D.G.A., Ghatei M.A., Bloom S.R. The central effects of orexin-A in the hypothalamic-pituitary-adrenal axis in vivo and in vitro in male rats. Journal of Neuroendocrinology. 13:2001;561-566.
66. Saphier D., Feldman S. Paraventricular nucleus neuronal responses following electrical stimulation of the midbrain dorsal raphe: Evidence for cotransmission. Experimental Brain Research. 78:1989;407-414.
67. Seasholtz A.F., Bourbonais F.J., Harnden C.E., Camper S.A. Nucleotide sequence and expression of the mouse corticotropin-releasing hormone gene. Molecular and Cellular Neuroscience. 2:1991;266-273.
68. Shibahara Y., Morimoto Y., Furutani M., Notake H., Takahashi S., Shimizu S., Horikawa S., Numa S. Isolation and sequence analysis of the human corticotropin-releasing factor precursor gene. EMBO Journal. 2:1983;775-779.
69. Stephanou A., Melino G., Knight R.A., Annicchiarico-Petruzzelli M., Sarlis N.J., Finazzi-Agro A., Lightman S.L. Interleukin-6 and corticotrophin-releasing hormone mRNA are modulated during differentiation of human neuroblastoma cells. Neuropeptides. 23:1992;45-49.
70. Stotz-Potter E.H., Morin S.M., DiMicco J.A. Effect of microinjection of muscimol into the dorsomedial or paraventricular hypothalamic nucleus on air-stress-induced neuroendocrine and cardovascular changes in rats. Brain Research. 742:1996;219-224.
71. Suda T., Tozawa F., Iwai I., Sato Y., Sumitomo T., Nakano Y., Yamada M., Demura H. Neuropeptide Y increases the corticotropin-releasing factor messenger ribonucleic acid level in the rat hypothalamus. Molecular Brain Research. 18:1993;311-315.
72. Suda T., Yajima F., Tomori N., Demura H., Shizume K. In vitro study of immunoreactive corticotropin-releasing factor release from the rat hypothalamus. Life Sciences. 37:1985;1499-1505.
73. Suda T., Yajima F., Tomori N., Sumitomo T., Nakagami Y., Ushiyama T., Demura H., Shizume K. Inhibitory effect of norepinephrine on immunoreactive corticotropin-releasing factor release from the rat hypothalamus in vitro. Life Sciences. 40:1987;1645-1649.
74. Sumitomo T., Suda T., Nakano Y., Tozawa F., Yamada M., Demura H. Angiotensin II increases the corticotropin-releasing factor messenger ribonucleic acid level in the rat hypothalamus. Endocrinology. 128:1991;2248-2252.
75. Swanson L.W., Simmons D.M. Differential steroid hormone and neural influence on peptide mRNA levels in CRH cells of the paraventricular nucleus: A hybridization histochemical study in the rat. Journal of Comparative Neurology. 285:1989;413-435.
76. Szafarczyk A., Feuvrier E., Siaud P., Rondouin G., Lacoste M., Gaillet S., Malaval F., Assenmacher I. Removal of adrenal steroids from the medium reverses the stimulating effect of catecholamines on corticotropin-releasing hormone neurons in organotypic cultures. Neuroendocrinology. 61:1995;517-524.
77. Tazi A., Swerdlow N.R., Le Moal M., Rivier J., Vale W., Koob G.F. Behavioral activation of CRF: evidence for the involvement of the ventral forebrain. Life Sciences. 41:1987;41-50.
78. Vale W., Speiss J., Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin. Science. 213:1981;1394-1397.
79. Vale W., Vaughan J., Yamamoto G., Bruhn T., Douglas C., Dalton D., Rivier C., Rivier J. Assay of corticotropin-releasing factor. Conn P.M. Methods Enzymol. vol. 103:1983;565 Academic Press, NY.
80. Vallieres L., Rivest S. Interleukin-6 is a needed proinflammatory cytokine in the prolonged neural activity and transcriptional activation of corticotropin-releasing factor during endotoxemia. Endocrinology. 140:1999;3890-3903.
81. Vamvakopoulos N.C., Karl M., Mayol V., Gomez T., Statakis C.A., Margioris A., Chrousos G.P. Structural Analysis of the Regulatory Region of the Human Corticotropin Releasing Hormone Gene. FEBS Letters. 267:1990;1-5.
82. Widmaier E.P., Lim A.T., Vale W. Secretion of corticotropin-releasing factor from cultured rat hypothalamic cells: Effects of catecholamines. Endocrinology. 124:1989;583-590.
83. Young W.S. III, Walker L.C., Powres R.E., DeSouza E.B., Price D.L. Corticotropin-releasing factor mRNA is expressed in the inferior olive of rodents and primates. Brain Research. 387:1986;189-192.